Position in FULC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,142,448
-$1,308,117 QoQ
Shares Held
3,044,385
+87.5% QoQ
Ownership
3.99%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#6
of 154 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in FULC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,017,559,982 across 217 Biotechnology names. FULC ranks #70 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in FULC
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,142,448 | 3,044,385 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $12,450,565 | 1,623,281 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $21,644,568 | 1,913,755 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $13,334,691 | 1,449,423 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $8,095,771 | 1,176,711 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,672,303 | 580,661 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,741,054 | 583,203 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,705,099 | 757,731 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,669,066 | 591,785 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,901,660 | 625,176 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,359,332 | 497,679 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $982,411 | 221,264 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $482,532 | 146,222 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $43,670 | 15,323 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,282,342 | 176,146 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $666,122 | 82,339 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $683,461 | 139,482 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $12,946,104 | 547,404 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $15,074,498 | 852,148 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $22,514,429 | 798,101 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||